![]() |
市場調查報告書
商品編碼
1859815
全球寵物輔助治療服務市場:預測至2032年-按動物類型、治療方法類型、應用、最終使用者和地區分類的分析Pet-Assisted Therapy Services Market Forecasts to 2032 - Global Analysis By Animal Type (Dogs, Cats and Other Companion Animals), Therapy Type, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2025 年,全球寵物輔助治療服務市場規模將達到 2.777 億美元,到 2032 年將達到 4.914 億美元,預測期內複合年成長率為 8.5%。
寵物輔助治療服務,也稱為動物輔助治療(AAT),是指以結構化的方式利用訓練有素的動物來支持患者的生理、情緒、認知或社交復健。這些服務由醫療專業人員根據書面治療方案提供,通常針對焦慮症、憂鬱症、創傷後壓力症候群(PTSD)和運動障礙等疾病。常見的治療動物包括狗、馬,有時也包括貓和小哺乳動物,它們的選擇取決於治療目標。與動物互動可以減輕壓力、改善情緒、增強溝通能力並提高積極性。與隨意的動物互動不同,寵物輔助治療以目標為導向,效果可衡量,並融入更廣泛的臨床和復健護理策略中。
提高對心理健康的認知
人們對心理健康的日益關注是寵物輔助治療服務市場發展的強勁驅動力。對壓力、焦慮、憂鬱症和社交孤立的日益重視,促使醫療機構、學校和復健中心採用動物輔助療法。治療動物有助於改善情緒健康、減少孤獨感並增強社交互動,使治療項目更具吸引力和有效性。這一趨勢透過鼓勵新的措施、擴大患者服務範圍以及增加全球對認證治療動物和訓練有素人員的需求,推動了市場成長。
權限有限,且人員受過訓練。
寵物輔助治療計畫資源有限以及訓練有素的人員短缺是寵物輔助治療服務市場發展的重大障礙。許多地區缺乏合格的訓犬員和訓練有素的動物,導致醫院、學校和養老院等機構的服務覆蓋範圍受限。這種短缺會延誤專案實施,減少病患數量,並影響服務品質。因此,企業在滿足日益成長的動物輔助治療性介入需求和擴大業務規模方面面臨挑戰,從而限制了市場擴張。
臨床檢驗和研究支持
臨床檢驗和不斷增加的研究支持是寵物輔助治療服務市場成長要素。科學研究證實了寵物輔助治療的顯著益處,例如減輕壓力、改善認知功能和提升情緒健康,從而增強了醫療保健提供者、學校和看護者的信任。實證結果鼓勵治療計畫的廣泛應用,吸引資金,並支持政策整合。這種檢驗不僅增強了相關人員的信心,也促進了認證治療動物計畫的擴展,從而推動了全球市場的成長。
高營運成本
高昂的營運成本對寵物輔助治療服務市場構成重大挑戰。動物照顧、訓練、認證、保險和運輸等相關費用對預算造成了巨大壓力,尤其對於小型非營利組織而言更是如此。這些財務負擔限制了計畫的擴張,降低了病患的就醫便利性,並減緩了醫療和教育機構對該服務的接受度。因此,服務提供者難以在維持服務品質和合規性的同時,繼續進行治療項目,從而阻礙了市場成長。
新冠疫情的影響
新冠疫情對寵物輔助治療服務市場造成了嚴重衝擊,社交隔離、封鎖措施和衛生方面的擔憂限制了治療動物與患者之間的面對面互動。許多計畫被迫關閉或縮減營運規模,對心理健康和復健服務造成了影響。雖然線上治療作為替代方案出現,但由於缺乏與動物的面對面互動,其效果有所降低。要恢復市場成長,需要重新進行安全的線下治療,並調整衛生防疫通訊協定。
預計在預測期內,犬類輔助治療領域將成為最大的細分市場。
由於犬類具有高度反應性、情緒智商高且易於訓練等優點,預計在預測期內,犬類輔助治療領域將佔據最大的市場佔有率。犬類能夠與患者建立牢固的聯繫,使其成為治療焦慮症、創傷後壓力症候群(PTSD)和發展障礙的理想選擇。犬類在不同文化和臨床環境中的廣泛接受度使其能夠大規模推廣應用。醫院、學校和養老機構擴大採用治療犬,進一步鞏固了治療犬的市場地位,並推動了其在各種治療應用領域持續成長的需求。
預計在預測期內,康復中心細分市場將以最高的複合年成長率成長。
預計在預測期內,康復中心領域將迎來最高的成長率。這些中心擴大採用結構化的動物互動療法來促進復原、改善運動協調能力並增強情緒韌性。對整體照護模式的投資不斷增加,以及越來越多的臨床證據支持治療動物的有效性,都推動了這種療法的應用。此外,長期照護機構對非藥物療法的支持和認知度不斷提高,也使這一領域受益匪淺。
由於人們對心理健康的日益關注、醫療基礎設施的不斷完善以及文化上對與動物互動的開放態度,預計亞太地區將在預測期內佔據最大的市場佔有率。日本、中國和印度等國家在健康計劃、老年護理和兒童治療中擴大採用治療動物。政府為促進心理健康和情緒健康所採取的舉措,以及都市區寵物飼養量的增加,都在推動市場需求。該地區憑藉其龐大的人口基數和不斷發展的治療規範,已成為重要的成長中心。
由於法律規範健全且寵物輔助療法被廣泛接受,預計北美地區在預測期內將呈現最高的複合年成長率。美國和加拿大在心理健康、復健和教育領域採用治療動物方面處於領先地位。焦慮症和創傷後壓力症候群(PTSD)的日益普遍,尤其是在退伍軍人和青少年群體中,正在推動治療動物的普及。有利的保險覆蓋範圍、不斷發展的治療動物訓練計畫以及醫療機構的大力支持,都促進了全部區域市場的快速擴張。
According to Stratistics MRC, the Global Pet-Assisted Therapy Services Market is accounted for $277.7 million in 2025 and is expected to reach $491.4 million by 2032 growing at a CAGR of 8.5% during the forecast period. Pet-Assisted Therapy Services, also known as Animal-Assisted Therapy (AAT), involve the structured use of trained animals to support physical, emotional, cognitive, or social healing. These services are delivered by healthcare professionals as part of a documented treatment plan, often targeting conditions like anxiety, depression, PTSD, or motor impairments. Common therapy animals include dogs, horses, and occasionally cats or small mammals, chosen based on therapeutic goals. Interaction with animals can reduce stress, improve mood, enhance communication, and boost motivation. Unlike casual animal visits, pet-assisted therapy is goal-oriented, measurable, and integrated into broader clinical or rehabilitative care strategies.
Rising Mental Health Awareness
The growing awareness of mental health is a strong driver for the Pet-Assisted Therapy Services Market. Increasing recognition of stress, anxiety, depression, and social isolation has led healthcare providers, schools, and rehabilitation centers to adopt animal-assisted interventions. Therapy animals help improve emotional well-being, reduce loneliness, and enhance social interaction, making programs more appealing and effective. This trend fuels market growth by encouraging new initiatives, expanding patient reach, and boosting demand for certified therapy animals and trained personnel globally.
Limited Access & Trained Personnel
Limited access to therapy programs and a shortage of trained personnel significantly hinder the Pet-Assisted Therapy Services Market. Many regions lack certified handlers and properly trained animals, restricting service availability to hospitals, schools, and care facilities. This scarcity slows program implementation, reduces patient reach, and impacts service quality. Consequently, market expansion is constrained, as organizations face challenges in scaling operations and meeting growing demand for animal-assisted therapeutic interventions.
Clinical Validation & Research Support
The rise in clinical validation and research support is a significant growth driver for the Pet-Assisted Therapy Services Market. Scientific studies demonstrating measurable benefits-such as reduced stress, improved cognitive function, and enhanced emotional well-being-boost credibility among healthcare providers, schools, and caregivers. Evidence-based outcomes encourage wider adoption of therapy programs, attract funding, and support policy integration. This validation not only enhances stakeholder confidence but also promotes the expansion of certified therapy animal programs, fueling global market growth.
High Operational Costs
High operational costs pose a major challenge to the Pet-Assisted Therapy Services Market. Expenses related to animal care, training, certification, insurance, and transportation strain budgets, particularly for non-profit and small-scale providers. These financial burdens limit program expansion; reduce accessibility for patients, and slow adoption in healthcare and educational institutions. Consequently, market growth is hindered, as organizations struggle to sustain services while maintaining quality and regulatory compliance in therapy programs.
Covid-19 Impact
The COVID-19 pandemic significantly disrupted the Pet-Assisted Therapy Services Market, as social distancing, lockdowns, and hygiene concerns limited in-person interactions between therapy animals and patients. Many programs faced suspension or reduced operations, impacting mental health and rehabilitation services. While virtual therapy sessions emerged as an alternative, the lack of direct animal contact reduced effectiveness. Recovery depends on resuming safe, in-person sessions and adapting hygiene protocols to restore market growth.
The canine-assisted therapy segment is expected to be the largest during the forecast period
The canine-assisted therapy segment is expected to account for the largest market share during the forecast period, due to dogs' high responsiveness, emotional intelligence, and ease of training. Their ability to form strong therapeutic bonds with patients makes them ideal for treating anxiety, PTSD, and developmental disorders. Dogs are widely accepted across cultures and clinical settings, enabling scalable deployment. Increasing integration of therapy dogs in hospitals, schools, and elder care facilities further strengthens their market position, driving sustained demand across diverse therapeutic applications.
The rehabilitation centers segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the rehabilitation centers segment is predicted to witness the highest growth rate, due to growing adoption of pet-assisted therapy in post-trauma and physical rehabilitation programs. These centers increasingly integrate structured animal interactions to accelerate recovery, improve motor coordination, and enhance emotional resilience. Rising investments in holistic care models and expanding clinical evidence supporting therapy animal efficacy are catalyzing adoption. The segment benefits from institutional support and growing awareness of non-pharmacological healing approaches in long-term care.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising mental health awareness, expanding healthcare infrastructure, and cultural openness to animal companionship. Countries like Japan, China, and India are witnessing increased integration of therapy animals in wellness programs, elder care, and pediatric therapy. Government initiatives promoting mental health and emotional well-being, coupled with growing urban pet ownership, are fueling demand. The region's large population base and evolving therapeutic norms position it as a key growth hub.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to strong regulatory frameworks, and widespread acceptance of pet-assisted therapy. The U.S. and Canada lead in integrating therapy animals into mental health, rehabilitation, and educational settings. Rising prevalence of anxiety and PTSD, especially among veterans and youth, is accelerating adoption. Favorable insurance coverage, expanding training programs for therapy animals and robust advocacy from healthcare institutions contribute to rapid market expansion across the region.
Key players in the market
Some of the key players profiled in the Pet-Assisted Therapy Services Market include Zoetis, Dogs for Better Lives, Merck Animal Health, Green Chimneys, Mars Petcare, PetSmart Charities, Elanco Animal Health, PAWS With A Cause, IDEXX Laboratories, HABRI (Human Animal Bond Research Institute), Pet Partners, Assistance Dogs International, Therapy Dogs International, Canine Companions for Independence and Delta Society Australia.
In June 2025, Mars Petcare, in collaboration with Big Idea Ventures, launched the 2025 Global Next Generation Pet Food Program. This initiative aims to accelerate sustainable innovation in the pet food sector by supporting startups with novel ingredients, sustainable fats and proteins, and advanced processing technologies.
In March 2025, Elanco signed a research agreement with WEDterinary LLC, co-founded by William Doyle, to explore novel therapies for chronic kidney disease in cats and investigate approaches to extend the healthy lifespan of pets. The collaboration aims to leverage gene therapy and AI technologies to advance pet healthcare.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.